Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia-Reference-Cited by-同舟云学术

Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia

Published:2022-10 Issue: Volume:Volume 14 Page:1901-1917
ISSN:1179-1608
Container-title:Nature and Science of Sleep
language:en
Short-container-title:NSS

Author:

Thorpy Michael J,Arnulf Isabelle,Foldvary-Schaefer Nancy,Morse Anne Marie^ORCID,Šonka Karel^ORCID,Chandler Patricia,Hickey Luke^ORCID,Chen Abby,Black Jed,Sterkel Amanda,Chen Dan,Bogan Richard K^ORCID,Dauvilliers Yves

Publisher

Informa UK Limited

Subject

Behavioral Neuroscience,Applied Psychology

Reference45 articles.

1. Idiopathic hypersomnia

2. Idiopathic Hypersomnia

3. American Academy of Sleep Medicine. Idiopathic hypersomnia. In: International Classification of Sleep Disorders.3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.

4. Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness

5. Precision Medicine for Idiopathic Hypersomnia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical considerations in the treatment of idiopathic hypersomnia;Sleep Medicine;2024-07

2. Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations;Neurology and Therapy;2024-04-25

3. Brain fog in central disorders of hypersomnolence: a review;Journal of Clinical Sleep Medicine;2024-04

4. Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia;Journal of Clinical Sleep Medicine;2023-10

5. Idiopathic hypersomnia: the long journey from classification to an efficacious drugCommentary on Morse AM, Dauvilliers Y, Arnulf I, et al. Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia. J Clin Sleep Med . 2023;19(10):1811–1822. doi:10.5664/jcsm.10698;Journal of Clinical Sleep Medicine;2023-10